FDA campaign F-1704-2024
Class IIIHazard
Customer complaint for bloated bottles. Testing and examination of these lots has revealed they did not meet specifications, including elevated pH and water activity levels. This may be indicative of microbiological activity, and concurrent risk of food-borne illness.
Distribution
CT, DE, MD, NJ, NY
REKALLD area-alert coverage: CT, DE, MD, NJ, NY (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.